Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1995 1
1996 2
1997 1
2000 2
2001 3
2002 8
2003 5
2004 7
2005 10
2006 5
2007 5
2008 12
2009 14
2010 17
2011 12
2012 7
2013 11
2014 12
2015 8
2016 5
2018 1
2019 2
2020 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C; FREEDOM Trial. Cummings SR, et al. N Engl J Med. 2009 Aug 20;361(8):756-65. doi: 10.1056/NEJMoa0809493. Epub 2009 Aug 11. N Engl J Med. 2009. PMID: 19671655 Free article. Clinical Trial.
Management of corticosteroid-induced osteoporosis.
Adachi JD, Olszynski WP, Hanley DA, Hodsman AB, Kendler DL, Siminoski KG, Brown J, Cowden EA, Goltzman D, Ioannidis G, Josse RG, Ste-Marie LG, Tenenhouse AM, Davison KS, Blocka KL, Pollock AP, Sibley J. Adachi JD, et al. Among authors: olszynski wp. Semin Arthritis Rheum. 2000 Feb;29(4):228-51. doi: 10.1016/s0049-0172(00)80011-6. Semin Arthritis Rheum. 2000. PMID: 10707991 Review.
Alendronate for the treatment of osteoporosis in men.
Olszynski WP, Davison KS. Olszynski WP, et al. Expert Opin Pharmacother. 2008 Feb;9(3):491-8. doi: 10.1517/14656566.9.3.491. Expert Opin Pharmacother. 2008. PMID: 18220499 Review.
Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.
Brown JP, Morin S, Leslie W, Papaioannou A, Cheung AM, Davison KS, Goltzman D, Hanley DA, Hodsman A, Josse R, Jovaisas A, Juby A, Kaiser S, Karaplis A, Kendler D, Khan A, Ngui D, Olszynski W, Ste-Marie LG, Adachi J. Brown JP, et al. Among authors: olszynski w. Can Fam Physician. 2014 Apr;60(4):324-33. Can Fam Physician. 2014. PMID: 24733321 Free PMC article. Review.
Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment.
Olszynski WP, Shawn Davison K, Adachi JD, Brown JP, Cummings SR, Hanley DA, Harris SP, Hodsman AB, Kendler D, McClung MR, Miller PD, Yuen CK. Olszynski WP, et al. Clin Ther. 2004 Jan;26(1):15-28. doi: 10.1016/s0149-2918(04)90002-1. Clin Ther. 2004. PMID: 14996514 Review.
Subsequent entry biologics/biosimilars: a viewpoint from Canada.
Russell AS, Ahluwalla V, Barnabe C, Jamal S, Offer RC, Olszynski WP, Shojania K, Haraoui B. Russell AS, et al. Among authors: olszynski wp. Clin Rheumatol. 2012 Sep;31(9):1289-92. doi: 10.1007/s10067-012-2066-5. Epub 2012 Aug 26. Clin Rheumatol. 2012. PMID: 22923182 Review.
Canadian recommendations for use of methotrexate in patients with rheumatoid arthritis.
Katchamart W, Bourré-Tessier J, Donka T, Drouin J, Rohekar G, Bykerk VP, Haraoui B, Leclerq S, Mosher DP, Pope JE, Shojania K, Thomson J, Thorne JC, Bombardier C; Canadian 3e Initiative Consensus Group. Katchamart W, et al. J Rheumatol. 2010 Jul;37(7):1422-30. doi: 10.3899/jrheum.090978. Epub 2010 Jun 1. J Rheumatol. 2010. PMID: 20516029 Free article. Review.
124 results